BioEP

BioEP is a seizure susceptibility assessment technology that can provide objective support to clinicians enabling faster and more accurate diagnosis and prognosis of epilepsy.

Epilepsy is a serious neurological condition that impacts over 65M people around the world.

BioEP is a patented seizure risk score calculated from routine EEG recordings that can enable faster and more accurate diagnosis and prognosis of epilepsy.

Neuronostics is a collaborative organisation and welcomes enquiries from researchers, clinicians and commercial partners.

We are Neuronostics

Neuronostics is a fast growing med-tech company, passionate about using research to improve the lives of people with epilepsy.

We are developing a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP.

Our goal at Neuronostics is to improve the quality of life of people with epilepsy, those suspected of having epilepsy and those family and friends who share their lives with them.

We are working in partnership with members of the public, people with epilepsy, special interest groups, researchers, doctors and neurologists, to bring the benefits of #BioEP to the wider community globally.

LATEST NEWS
Find out the latest news and information from Neuronostics.

Paid marketing opportunity for Bristol student

We’re offering a paid internship for an eligible student from the University of Bristol. This is a flexible opportunity for current UoB students, or those that have completed their degree within the... [Read More]

New data role for Neuronostics

We’re looking for a data scientist to join the Neuronostics team! This is a new role that will help provide insights and a deeper understanding of clinical data sets.  You’ll work closely... [Read More]

New clinical role for Neuronostics

We’re looking for a clinical scientist to join the team! This role will be our in-house expert on all things clinical.  Supporting our technical, scientific and commercial teams to ensure that we’re... [Read More]